These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Central injection of astressin inhibits carbon tetrachloride-induced acute liver injury in rats.
    Author: Nakade Y, Yoneda M, Yokohama S, Tamori K, Nakamura K, Watanobe H, Kono T, Makino I, Terano A.
    Journal: Eur J Pharmacol; 2003 Jan 24; 460(2-3):135-8. PubMed ID: 12559373.
    Abstract:
    The effect of intracisternal astressin, a specific and potent corticotropin-releasing factor (CRF)(1) and CRF(2) receptor antagonist on carbon tetrachloride (CCl(4))-induced acute liver injury was investigated in rats. Intracisternal astressin inhibited the elevation of serum alanine aminotransferase level induced by CCl(4). Intracisternal astressin also reduced CCl(4)-induced liver histological changes. The protective effect of central astressin on CCl(4)-induced liver damage was abolished by sympathectomy but not by hepatic branch vagotomy. These findings demonstrate that astressin acts in the central nervous system to induce hepatic cytoprotection, possibly through the sympathetic pathways in rats. These results further establish a role of endogenous CRF in the brain in hepatic pathophysiological regulation.
    [Abstract] [Full Text] [Related] [New Search]